Top

BY Meagan Raeke

Oropharyngeal cancer includes cancers of the tonsils, base of the tongue and other parts of the throat. It’s usually caused by the human papillomavirus (HPV). People who have successfully completed treatment for HPV-related oropharyngeal cancer often have a good prognosis and are able to return to their daily lives.

But survivors may go on to develop voice and speech symptoms years after treatment. Moderate to severe voice symptoms...

BY Meagan Raeke

Smoking is the No. 1 cause of lung cancer. Yet, about 20% of lung cancers deaths occur in people who have never smoked, according to the American...

BY Meagan Raeke

Today, the U.S. Preventive Services Task Force (USPSTF) released new guidelines for annual lung cancer screening through low-dose CT scans...

BY Meagan Raeke

As a health care quality professional, Al Thomas always made his annual physical a priority. When he went to see his primary care physician in Lexington, South Carolina, in January 2020, Al asked about his risk for colorectal cancer, even though at 38, he hadn’t reached the recommended age for a screening colonoscopy.

Al’s cousin and lifelong best friend had just been diagnosed with advanced colorectal cancer. He died a few months...

Colorectal cancer survivor Al Thomas with his wife, Demetria, and their kids

BY Meagan Raeke

When Tim Hardesty walks the MD Anderson skybridge in short sleeves, he’s frequently stopped by employees and patients alike who notice the...

BY Meagan Raeke

Magnetic resonance imaging (MRI) is a type of imaging test that’s used to diagnose cancer and monitor tumor growth.

“MRI is an excellent...

BY Meagan Raeke

Pancreatic cancer only accounts for about 3% of cancers diagnosed in the U.S. each year, but it is the third most common cause of cancer-related...

BY Meagan Raeke

Your body is home to trillions of microbes. These bacteria, viruses, fungi and other organisms impact everything from how you process food...

BY Meagan Raeke

For patients with non-small cell lung cancer (NSCLC) with EGFR mutations, targeted therapy with EGFR tyrosine kinase inhibitors (TKIs) has...